Log In
BCIQ
Print this Print this
 

ASP6432

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsTreat lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today